John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 20,000 shares at $32.34 ($636K) on 2015-05-11, disclosed to the SEC on 2015-05-13.
Scheduled sale ($636k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.77 | 19,100 | $607K | 95.4% |
| 2 | $32.34 | 900 | $29K | 4.6% |
| Total | $31.80 avg | 20,000 | $636K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |